| Medicare program; modification to the weighting methodology used to calculate the low-income benchmark amount. Final rule. | |
| | |
MedLine Citation:
|
PMID: 18464346 Owner: HSR Status: MEDLINE |
Abstract/OtherAbstract:
|
This final rule changes the weighting methodology used to calculate the low-income benchmark premium amount (benchmark) for 2009 and thereafter. Under this final rule, the benchmark weighting methodology is adjusted so that the relative weights of the Medicare Advantage Prescription Drug (MA-PD) plan premiums and Prescription Drug Plan (PDP) plan premiums in the low-income benchmark premium amount reflect the distribution of enrollment of beneficiaries eligible for the low-income subsidy in each plan. |
| | |
Authors:
|
|
Related Documents
:
|
16751326 - Drug benefit decisions among older adults: a policy-capturing analysis. 9781826 - The legal importation of prescription drugs into the united states from mexico: a study... 11727966 - Compliance with prescription recommendations by physicians in practices. 17567236 - Consumer response to dual incentives under multitiered prescription drug formularies. 7949746 - Pharmacokinetic model of intravitreal drug injection. 1097256 - Facilitation through hyperventilation of therapeutic effect of pyrithioxin in cerebral ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Federal register Volume: 73 ISSN: 0097-6326 ISO Abbreviation: Fed Regist Publication Date: 2008 Apr |
Date Detail:
|
Created Date: 2008-05-08 Completed Date: 2008-05-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7808722 Medline TA: Fed Regist Country: United States |
Other Details:
|
Languages: eng Pagination: 18176-82 Citation Subset: T |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Benchmarking
/
legislation & jurisprudence* Cost Sharing / legislation & jurisprudence* Drug Costs / legislation & jurisprudence* Humans Medicare Part D / legislation & jurisprudence* Poverty United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Revised medical criteria for evaluating immune system disorders. Final rules.
Next Document: A martyr for modernity: Qiu Jin, feminist warrior and revolutionary.